glossari
eia
enzym
immunoassay
method
use
estim
virusspecif
igg
igm
antibodi
viru
antigen
enzymelabel
conjug
pcr
polymeras
chain
reaction
pcr
specif
primer
dna
sequenc
multipli
rtpcr
rna
nucleic
acid
transcrib
revers
transcriptas
rt
enzym
complementari
dna
prior
pcr
specif
viru
diagnost
use
determin
etiolog
acut
viral
infect
reactiv
latent
infect
two
approach
use
demonstr
specif
antibodi
respons
presenc
viru
nucleic
acid
test
becom
main
approach
demonstr
presenc
viru
cultiv
use
fewer
special
laboratori
antigen
detect
method
move
point
care
serolog
method
use
measur
antibodi
respons
caus
activ
infect
articl
briefli
describ
principl
import
serolog
method
molecular
applic
use
provid
inform
viral
etiolog
clinic
condit
presum
caus
viral
infect
diagram
cours
acut
viru
infect
figur
indic
optim
method
viral
diagnosi
follow
transmiss
viru
start
multipli
incub
period
clinic
symptom
appear
simultan
shed
infecti
viru
presenc
infecti
viru
viral
structur
compon
investig
directli
variou
clinic
specimen
either
nucleic
acid
detect
assay
viru
isol
antigen
detect
assay
irrespect
method
direct
viru
detect
specimen
collect
site
symptom
give
conclus
diagnosi
virusspecif
antibodi
appear
somewhat
later
day
week
call
window
period
virusspecif
antibodi
product
reach
level
detect
first
immunoglobulin
igm
antibodi
day
later
immunoglobulin
g
igg
antibodi
appear
amount
infecti
viru
start
decreas
first
encount
particular
viru
primari
immun
respons
igg
antibodi
level
stay
rel
low
level
wherea
later
contact
antigen
secondari
respons
igg
level
increas
rapidli
reach
high
level
igm
respons
may
detect
antibodi
usual
investig
serum
sampl
taken
acut
convalesc
phase
infect
select
case
materi
cerebrospin
fluid
bodi
fluid
also
analyz
order
reach
best
diagnosi
patient
import
select
suitabl
method
use
right
sampl
collect
right
time
primari
infect
igm
antibodi
level
peak
day
onset
ill
start
declin
disappear
week
month
igm
respons
usual
detect
reactiv
infect
reinfect
product
igg
antibodi
start
day
igm
respons
antibodi
often
persist
throughout
life
serolog
diagnosi
usual
base
either
demonstr
presenc
specif
igm
antibodi
signific
increas
level
specif
igg
antibodi
two
consecut
sampl
taken
week
apart
antigen
test
either
viabl
inactiv
viru
compon
prepar
virolog
molecular
method
isotypespecif
marker
physic
separ
use
demonstr
isotyp
react
antibodi
case
even
igg
subclass
specif
determin
although
limit
valu
diagnost
work
earli
phase
primari
infect
specif
avid
igg
antibodi
usual
low
increas
matur
respons
diagnost
applic
measur
avid
igg
antibodi
specif
antigen
develop
help
distinguish
serolog
respons
due
acut
infect
chronic
past
infect
serolog
assay
use
mani
purpos
primari
infect
often
provid
inform
etiolog
even
acut
stage
infecti
viru
compon
longer
demonstr
sampl
wide
use
screen
blood
product
risk
certain
chronic
infect
evalu
immun
statu
need
prophylact
treatment
connect
certain
organ
transplant
serolog
may
also
use
confirm
acut
infect
case
viru
asymptomat
present
also
wide
use
epidemiolog
studi
determin
vaccineinduc
immun
similar
public
health
purpos
serolog
assay
limit
infect
antibodi
respons
strong
enough
limit
specif
antigen
use
assay
allow
unambigu
interpret
result
infect
newborn
presenc
matern
antibodi
may
render
demonstr
respons
babi
imposs
immunocompromis
patient
serolog
respons
often
weak
allow
demonstr
specif
respons
case
virolog
method
consid
clinic
specimen
sera
use
antibodi
assay
igm
igg
antibodi
determin
cerebrospin
fluid
use
diagnosi
viru
infect
central
nervou
system
although
new
molecular
method
increasingli
replac
recent
increas
attent
given
use
noninvas
sampl
materi
saliva
urin
becom
import
public
health
purpos
valu
diagnos
individu
patient
still
limit
antibodi
decreas
infecti
capac
viru
call
neutral
antibodi
produc
acut
infect
often
persist
entir
lifetim
also
use
indic
immun
igm
igg
antibodi
particip
neutral
assay
known
amount
infecti
viru
mix
serum
sampl
incub
short
period
residu
infect
measur
use
cell
cultur
test
anim
infect
compar
infect
origin
viru
neutral
capac
calcul
result
today
neutral
antibodi
assay
often
done
plaqu
reduct
assay
better
accuraci
somewhat
complex
technic
requir
neutral
antibodi
assay
specif
sensit
timeconsum
labori
therefor
wide
use
routin
diagnost
servic
mani
virus
bind
hemagglutinin
molecul
found
surfac
red
blood
cell
variou
anim
speci
caus
aggreg
red
cell
suitabl
condit
prevent
aggreg
call
hemagglutin
inhibit
specif
antivir
antibodi
patient
serum
wide
use
diagnost
purpos
test
known
hemagglutin
inhibit
test
import
diagnost
public
health
applic
certain
infect
notabl
influenza
antibodi
measur
test
show
addit
specif
compar
test
therefor
provid
detail
inform
immun
past
infect
individu
howev
diagnosi
individu
patient
assay
longer
wide
use
replac
modern
immunoassay
test
viru
prepar
predetermin
hemagglutin
capac
mix
serum
sampl
proper
incub
residu
hemagglutin
capac
measur
igm
igg
antibodi
abl
inhibit
hemagglutin
complement
fixat
test
cft
classic
laboratori
diagnost
test
still
use
determin
viru
antibodi
patient
sera
cerebrospin
fluid
sampl
acut
infect
test
mainli
measur
igg
antibodi
test
base
capac
complement
group
heatlabil
protein
present
plasma
warmblood
anim
bind
antigenantibodi
complex
complex
present
surfac
red
blood
cell
complement
caus
lysi
visual
suitabl
experiment
setup
actual
test
complement
patient
serum
first
destroy
heat
serum
mix
appropri
viral
antigen
incub
antigenantibodi
complex
form
exogen
complement
usual
fresh
guinea
pig
serum
ad
complement
bind
complex
fix
longer
abl
caus
lysi
ad
indic
red
cell
usual
sheep
red
cell
coat
antisheep
red
cell
antibodi
use
indic
measur
presenc
residu
complement
effect
measur
suitabl
test
protocol
serial
dilut
patient
serum
use
highest
dilut
serum
still
prevent
complement
activ
indic
system
taken
cft
titer
sampl
test
usual
carri
microtit
plate
result
observ
eye
cft
still
use
diagnosi
acut
viru
infect
measur
certain
type
antibodi
occur
acut
phase
infect
therefor
cft
suitabl
investig
immun
statu
assay
procedur
quit
complex
test
depend
sever
biolog
variabl
standard
pretest
method
less
sensit
mani
immunoassay
addit
method
labor
intens
amen
autom
use
cft
viru
diagnost
increasingli
replac
modern
immunoassay
immunoassay
antibodi
bind
specif
immobil
antigen
directli
observ
use
bound
antigen
proper
indic
label
antiimmunoglobulin
antibodi
antigen
immobil
plastic
microtit
plate
glass
slide
filter
paper
similar
materi
differ
immunoassay
nowaday
wide
use
measur
virusspecif
igm
igg
antibodi
recent
format
immunoassay
make
possibl
detect
simultan
antigen
antibodi
decreas
significantli
window
period
infect
immun
respons
numer
commerci
kit
high
specif
sensit
avail
autom
made
immunoassay
techniqu
rapid
accur
easier
perform
basic
format
solidphas
immunoassay
virusinfect
cell
cell
lysat
purifi
semipurifi
recombin
viral
antigen
synthet
peptid
immobil
solid
phase
usual
plastic
microtit
well
glass
slide
patient
serum
incub
antigen
bound
antibodi
wash
step
visual
use
label
antiimmunoglobulin
antibodi
conjug
figur
label
use
enzym
test
call
enzym
immunoassay
eia
enzymelink
immunosorb
assay
elisa
bound
antibodi
detect
enzymedepend
color
reaction
fluoresc
label
use
method
call
immunofluoresc
test
ift
enzym
label
commonli
use
horseradish
peroxidas
hrp
alkalin
phosphatas
ap
hrpeia
colorform
system
consist
orthophenyldiamin
opd
chromogen
hydrogen
peroxidas
h
substrat
hrpconjug
bound
antibodyantigen
complex
colorless
chromogen
becom
yellow
color
intens
measur
photomet
wavelength
nm
intens
color
proport
amount
bound
conjug
amount
specif
antibodi
patient
serum
sampl
serum
contain
specif
antibodi
conjug
bound
color
reaction
occur
use
either
antiigg
antiigm
conjug
possibl
determin
separ
immunoglobulin
subclass
specif
sensit
immunoassay
gener
high
common
sourc
potenti
misinterpret
fals
posit
igm
reaction
due
presenc
rheumatoid
factor
igm
molecul
react
virusspecif
igg
specif
improv
use
addit
incub
step
igm
antibodi
first
enrich
captur
sampl
use
antiigm
immunoglobulin
altern
igg
adsorb
block
serum
pretreat
immunofluoresc
test
use
past
measur
virusspecif
antibodi
replac
eia
techniqu
principl
method
similar
eia
ift
infect
cell
place
glass
slide
bound
antibodi
detect
fluoresceinlabel
antiimmunoglobulin
antibodi
glass
slide
examin
fluoresc
microscop
method
specif
sensit
quit
labor
intens
read
test
demand
consider
experi
infect
eg
caus
human
immunodefici
viru
hiv
antibodi
certain
compon
viru
inform
lessspecif
antibodi
detect
immunoblot
assay
differ
viru
antigen
prepar
gel
diffus
techniqu
absorb
discret
band
solid
strip
cellulos
similar
materi
strip
incub
patient
serum
antibodi
present
serum
bind
specif
antigen
detect
use
hrpconjug
nitroblu
tetrazolium
precipit
color
chromogen
color
reaction
observ
compar
posit
neg
control
sampl
assay
separ
strip
immunoblot
assay
commonli
use
confirm
highli
sensit
eia
screen
assay
result
antibodi
hiv
hepat
c
viru
hcv
human
tcell
lymphoma
viru
htlv
techniqu
known
lateralflow
technolog
also
use
identifi
antibodi
antigen
test
involv
applic
serum
sampl
directli
strip
suitabl
materi
cellulos
antibodi
diffus
later
eventu
reach
site
strip
appropri
antigen
appli
chemic
fix
specif
antibodi
becom
bound
site
nonreact
antibodi
diffus
area
presenc
antibodi
visual
use
label
conjug
although
test
quantit
valuabl
infect
presenc
specif
antibodi
indic
hiv
infect
perform
test
often
simpl
result
avail
minut
hour
make
test
suitabl
bedsid
screen
advanc
test
sever
differ
antibodi
detect
singl
assay
test
condit
modifi
antigen
also
detect
mani
test
becom
commerci
avail
recent
year
applic
coat
latex
particl
replac
strip
fix
antigen
solid
phase
bind
specif
antibodi
visual
chromogen
otherwis
label
indic
antibodi
posit
reaction
detect
agglutin
latex
particl
presenc
viral
antigen
clinic
specimen
nasopharyng
aspir
fecal
specimen
vesicl
fluid
tissu
specimen
well
serum
sampl
demonstr
antigen
detect
assay
immunofluoresc
test
cell
clinic
specimen
fix
glass
slide
viral
antigen
present
cell
detect
fluoresceinlabel
virusspecif
antibodi
less
readerdepend
result
obtain
use
enzym
immunoassay
solubil
antigen
clinic
specimen
first
captur
use
specif
monoclon
antibodi
bound
solid
phase
detect
virusspecif
detector
antibodi
figur
b
function
monoclon
antibodi
mab
high
specif
bind
affin
better
preserv
label
small
molecul
compar
bulki
enzym
molecul
eia
biotinyl
mab
use
streptavidinenzym
conjug
timeresolv
fluoroimmunoassay
trfia
detector
mab
label
europium
chelat
antigen
detect
method
especi
recommend
case
viru
reactiv
exampl
herp
simplex
varicella
zoster
viru
diagnosi
serolog
respons
weak
antigen
detect
assay
also
wide
use
respiratori
tract
infect
like
influenza
respiratori
syncyti
viru
infect
simpl
test
demonstr
rotaviru
adenoviru
antigen
children
gastroenter
also
avail
direct
demonstr
viral
nucleic
acid
clinic
sampl
becom
techniqu
widest
repertoir
diagnost
viru
target
use
polymeras
chain
reaction
pcr
specif
primer
viral
sequenc
rapidli
multipli
identifi
techniqu
larg
replac
classic
viru
isol
rapid
perform
mani
case
sensit
viru
isol
antigen
detect
method
make
earlier
diagnosi
possibl
prove
particularli
valuabl
diagnosi
emerg
virus
virus
cultiv
papillomavirus
parvovirus
hepat
virus
rhinoviru
speci
c
semiquantit
quantit
applic
develop
allow
monitor
viral
load
antivir
treatment
test
distinguish
viabl
replicationincompet
viru
warrant
caution
interpret
result
certain
case
sensit
crossov
contamin
throughout
diagnost
pathway
undermin
use
realtim
pcr
technolog
diminish
problem
clinic
laboratori
set
specif
test
base
extent
pairmatch
sequenc
viral
nucleic
acid
primer
extrem
high
sensit
typic
pcr
method
copi
viral
nucleic
acid
detect
one
hour
pcr
method
avail
rna
dna
virus
rna
virus
viral
nucleic
acid
transcrib
revers
transcriptas
rt
enzym
complementari
dna
combin
assay
call
rtpcr
viral
nucleic
acid
extract
sampl
materi
amplifi
three
success
step
doublestrand
dna
first
heatdenatur
separ
singl
strand
specif
target
fragment
dna
strand
amplifi
figur
pair
targetspecif
oligonucleotid
primer
anneal
one
strand
unfold
doublestrand
dna
anneal
primer
act
origin
heatstabl
polymeras
enzym
complementari
strand
synthes
via
sequenti
addit
deoxyribonucleotid
realtim
pcr
anneal
extens
step
often
combin
singl
step
c
cycl
repeat
time
cycl
result
exponenti
increas
number
copi
amplif
complet
product
detect
sever
method
agaros
gel
electrophoresi
combin
ethidium
bromid
stain
product
classic
method
figur
size
amplifi
product
compar
control
amplicon
standard
gel
variou
hybrid
assay
base
label
complementari
oligonucleotid
probe
also
use
improv
sensit
specif
detect
applic
larg
number
target
respiratori
viru
detect
papillomaviru
type
convent
pcr
postpcr
hybrid
still
popular
solut
product
highli
multiplex
pcr
assay
identifi
probe
hybrid
microarray
use
scan
fluoromet
fluoresc
microbead
use
flowcytometr
bead
count
amplifi
fragment
also
sequenc
give
addit
inform
viru
comparison
sequenc
known
viru
sequenc
allow
identif
speci
strain
subtyp
may
import
public
health
medic
purpos
sequenc
rtpcr
also
current
methodofchoic
investig
emerg
antivir
drug
resist
among
hivinfect
patient
realtim
pcr
instrument
monitor
accumul
amplicon
measur
fluoresc
continu
cycl
reaction
fluoresc
gener
dsdna
dye
fluoresc
probe
system
includ
reaction
mix
earlier
amplif
product
becom
detect
background
higher
amount
viru
sampl
figur
dsdna
dye
eg
sybr
green
react
dsdna
form
amplif
amplicon
specif
confirm
melt
curv
analysi
also
allow
test
one
viru
sampl
figur
mani
altern
probe
chemistri
realtim
pcr
common
includ
dual
label
probe
sinc
probe
usual
select
target
sequenc
primer
probe
base
realtim
pcr
method
offer
highest
specif
fastest
reaction
time
multichannel
instrument
allow
use
probe
differ
exit
emiss
spectra
simultan
detect
sever
differ
analyt
singl
tube
pcr
assay
extrem
sensit
therefor
influenc
inhibitor
polymeras
enzym
sometim
present
clinic
sampl
intern
control
includ
reaction
mixtur
nucleas
present
sampl
figur
rtpcr
realtim
detect
melt
curv
analysi
b
detect
respiratori
syncyti
viru
rsv
rhinoviru
enteroviru
respiratori
secret
c
c
threshold
cycl
number
melt
temperatur
ntc
nontempl
control
unpublish
result
wari
tevaluoto
sterback
r
reagent
also
caus
fals
neg
result
degrad
viral
nucleic
acid
furthermor
amplicon
may
also
caus
product
carryov
fals
posit
result
extrem
high
care
appli
handl
clinic
specimen
reagent
well
reaction
product
key
succes
pcr
method
care
design
primer
probe
specif
target
follow
certain
structur
rule
produc
effici
amplif
high
specif
pcr
especi
probebas
realtim
pcr
make
techniqu
sensit
mutat
sens
nonsens
target
sequenc
highli
variabl
virus
must
taken
consider
design
assay
also
continu
evalu
chang
sensit
caus
new
mutat
affect
critic
primer
probe
bind
site
one
great
advantag
pcr
technolog
potenti
detect
new
emerg
virus
use
primer
relat
virus
socal
gener
primer
import
inform
regard
new
viru
obtain
develop
specif
test
recent
exampl
middleeast
respiratori
syndrom
mer
coronaviru
specif
diagnost
test
becam
avail
soon
taxonom
posit
viru
becam
known
technolog
also
allow
safe
handl
transport
viru
sampl
sinc
extract
buffer
ad
sampl
inactiv
viru
infect
poc
test
becom
increasingli
common
clinic
practic
proper
use
offer
costeffici
diagnost
guidanc
quick
clinic
decis
make
perform
rare
good
correspond
laboratori
test
use
qualitycontrol
backup
arrang
virolog
lab
base
easytous
lateralflow
latex
particl
technolog
abl
give
result
minut
poc
test
nowaday
avail
antibodi
screen
increas
number
viru
infect
hiv
hepat
c
viru
hcv
varicellazost
viru
vzv
cytomegaloviru
cmv
epsteinbarr
viru
ebv
breakthrough
nucleic
acid
test
antigen
detect
method
becom
obsolet
highend
viru
laboratori
develop
continu
poc
test
commerci
avail
test
antigen
detect
later
flow
immunochromatograph
assay
typic
target
influenza
virus
respiratori
syncyti
viru
adenovirus
rotaviru
noroviru
hepat
b
viru
multianalyt
test
common
respiratori
viru
antigen
possibl
commersi
multianalyt
respiratori
infect
poc
test
platform
includ
small
benchtop
instrument
suitabl
polyclin
use
also
compact
allinon
pcr
system
detect
respiratori
pathogen
avail
driven
public
health
scientif
commerci
interest
new
diagnost
test
laboratori
diagnosi
viral
infect
continu
develop
develop
new
molecular
detect
method
continu
two
line
one
hand
includ
compact
fulli
integr
autom
requir
minim
train
run
suitabl
poc
use
hand
separ
instrument
specimen
handl
nucleic
acid
extract
pcr
setup
amplif
integr
high
throughput
flow
system
allow
effici
use
commerci
laboratori
design
assay
use
multianalyt
method
becom
practic
realiti
might
significantli
chang
diagnost
infecti
diseas
futur
multiplex
pcr
singl
tube
miniatur
format
still
challeng
reach
sensit
simpler
pcr
target
one
analyt
microarray
technolog
pcr
product
detect
compet
sequenc
still
provid
rapid
altern
identif
larg
number
viru
type
next
gener
sequenc
technolog
primari
way
identif
new
emerg
virus
simpl
microarray
readabl
without
bioinformat
would
reduc
cost
serolog
screen
allow
use
control
measur
improv
qualiti
result
outsid
specif
viru
diagnost
measur
viru
induc
interferon
respons
area
potenti
develop
